98 lines
2.6 KiB
Markdown
98 lines
2.6 KiB
Markdown
# Standard Operating Procedure: [Title]
|
|
|
|
| Document ID | SOP-XXX |
|
|
|-------------|---------|
|
|
| Title | [Title] |
|
|
| Revision | 1.0 |
|
|
| Effective Date | [DATE] |
|
|
| Author | [AUTHOR] |
|
|
| Approved By | [APPROVER] |
|
|
| Department | Pediatric Pharmacy |
|
|
|
|
---
|
|
|
|
## 1. Purpose
|
|
|
|
[State the purpose of this pediatric pharmacy procedure]
|
|
|
|
## 2. Scope
|
|
|
|
[Define the scope and applicability - specify age ranges (neonate, infant, child, adolescent) if relevant]
|
|
|
|
## 3. Responsibilities
|
|
|
|
### 3.1 Pediatric Pharmacist
|
|
- [Responsibility specific to pediatric pharmaceutical care]
|
|
- [Responsibility]
|
|
|
|
### 3.2 Pharmacy Technician (Pediatric-Trained)
|
|
- [Responsibility]
|
|
- [Responsibility]
|
|
|
|
### 3.3 [Other Role]
|
|
- [Responsibility]
|
|
- [Responsibility]
|
|
|
|
## 4. Definitions
|
|
|
|
| Term | Definition |
|
|
|------|------------|
|
|
| Neonate | Infant from birth to 28 days of age |
|
|
| Infant | Child from 29 days to 12 months of age |
|
|
| Child | Person from 1 year to 12 years of age |
|
|
| Adolescent | Person from 13 years to 18 years of age |
|
|
| Weight-based dosing | Medication dose calculated based on patient weight (mg/kg) |
|
|
| BSA-based dosing | Medication dose calculated based on body surface area (mg/m²) |
|
|
| Off-label use | Use of medication outside FDA-approved age, indication, or dosing |
|
|
| [Add other terms] | [Definition] |
|
|
|
|
## 5. Procedure
|
|
|
|
### 5.1 [Section Title]
|
|
|
|
[Procedure steps specific to pediatric pharmacy]
|
|
|
|
### 5.2 Dosing Verification (if applicable)
|
|
|
|
1. Verify patient weight and age
|
|
2. Calculate dose using appropriate formula
|
|
3. Verify dose is within age-appropriate range
|
|
4. Verify maximum dose not exceeded
|
|
5. Independent verification by second pharmacist
|
|
|
|
### 5.3 [Additional Section]
|
|
|
|
[Procedure steps]
|
|
|
|
## 6. Safety Considerations
|
|
|
|
[Pediatric-specific safety considerations, such as:]
|
|
- High-alert medication protocols
|
|
- Calculation verification requirements
|
|
- Age-appropriate formulation selection
|
|
- Dilution requirements for neonatal use
|
|
|
|
## 7. Related Documents
|
|
|
|
- [List related procedures, forms, dosing references, etc.]
|
|
- POL-001 Pediatric Pharmacy Quality Policy
|
|
- [Pediatric dosing guidelines]
|
|
|
|
## 8. References
|
|
|
|
- USP <795> Pharmaceutical Compounding - Nonsterile Preparations
|
|
- USP <797> Pharmaceutical Compounding - Sterile Preparations
|
|
- USP <800> Hazardous Drugs - Handling in Healthcare Settings
|
|
- ISMP Guidelines for Pediatric Medication Safety
|
|
- AAP/PPAG Pediatric Pharmacy Practice Guidelines
|
|
- [Facility-specific references]
|
|
- [State Board of Pharmacy regulations]
|
|
|
|
---
|
|
|
|
## Revision History
|
|
|
|
| Rev | Date | Description | Author |
|
|
|-----|------|-------------|--------|
|
|
| 1.0 | [DATE] | Initial release | [AUTHOR] |
|